(Q35631979)

9 August 2017

1 reference

title

Role of interleukin-2 activated MHC-nonrestricted lymphocytes in antileukemia activity and therapy (English)

1 reference

9 August 2017

Lotzová E

1

1 reference

9 August 2017

E. Lotzová

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1472926

30 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1472926

30 September 2022

publication date

1 May 1992

1 reference

9 August 2017

1 reference

9 August 2017

volume

7

1 reference

9 August 2017

issue

1-2

1 reference

9 August 2017

page(s)

15-28

1 reference

Inhibition of clonogenic growth of fresh leukemia cells by unstimulated and IL-2 stimulated NK cells of normal donors

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199209053598

Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209053598

NKR-P1, a signal transduction molecule on natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209053598

Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209053598

Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209053598

„Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209053598

Effects of a cloned cell line with NK activity on bone marrow transplants, tumour development and metastasis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209053598

Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209053598

Natural killer cells: immunobiology and clinical prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209053598

Feeder cells enhance oncolytic and proliferative activity of long-term human bone marrow interleukin-2 cultures and induce different lymphocyte subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209053598

Generation of cytotoxic NK cells in peripheral blood and bone marrow of patients with acute myelogenous leukemia after continuous infusion with recombinant interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209053598

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209053598

In vivo effect of anti-asialo GM1 antibody on natural killer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209053598

10.3109/10428199209053598

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference